News and Trends 4 Feb 2021 HIV Drug Approvals Lift Hopes Amid Missed UN Targets The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers around the world. However, a vital UN deadline for improving global HIV healthcare has slipped away. At the end of January, ViiV Healthcare’s Cabenuva became the first long-acting HIV treatment to be approved by the FDA. This decision, in addition […] February 4, 2021 - 6 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 3 Feb 2021 Detecting Gene-Edited Food: The EU’s Nightmare The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The EU has some of the strictest food regulations in the world surrounding the cultivation and commercialization of genetically modified organisms (GMOs), which it defines as organisms whose […] February 3, 2021 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 1 Feb 2021 Democratized DNA Synthesis: A Game-Changer Against Covid-19 DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect research from future disruptions by giving every lab the ability to synthesize its own DNA molecules. The Covid-19 pandemic has highlighted more than ever the […] February 1, 2021 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 27 Jan 2021 Single-Cell Sequencing: Paving the Way for Precision Medicine Next-generation sequencing techniques to determine an individual’s unique genetic code gave rise to personalized treatments. Single-cell sequencing is the next step towards making precision medicine more accurate. Each cell in our body is unique. Even genetically identical cells can behave differently in response to a certain treatment. With next-generation sequencing, scientists can study how the […] January 27, 2021 - 7 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2021 Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been approved by the FDA and EMA. However, we’re seeing the first signs that the Covid-19 pandemic may help the field get out of the rut. Earlier this month, the Oxford-based firm Theolytics raised €5.6M in a Series A round. This […] January 26, 2021 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2021 Biotech Drives the Water Purification Industry Towards a Circular Economy Water purification has never been more important, but antiquated methods and a lack of innovation have held the sector back. Biotechnology proposes solutions that bring us one step closer to a true circular economy. Rising populations and pollution levels mean that water purification is now more crucial than ever before. However, much of the industry […] January 20, 2021 - 10 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2021 GSK Acne Deal Heralds Growing Interest in Skin Microbiome This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal focused on the skin microbiome, receiving up to €185M from GlaxoSmithKline (GSK) as they explore a CRISPR-based treatment for acne. Acne is a condition that troubles the majority of adolescents and often persists into adulthood. […] January 15, 2021 - 4 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
Inside Labiotech 14 Jan 2021 Labiotech.eu Gets a Facelift for 2021 Happy New Year, and welcome to the new Labiotech.eu! We decided to surprise you with a fresh look to start 2021. In the last couple of months, we’ve been working hard to create a better website experience. Here are some details on what you can expect from this new design. A better reading experience Over […] January 14, 2021 - 6 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
Expert Advice 13 Jan 2021 How Much Control Should Investors Have Over Your Biotech Company? While getting funding from a star investor can be great for business, many biotech entrepreneurs dread the possibility of investors taking control in a situation that eerily resembles a hostile takeover. But it needn’t be that way at all. Biotech founders often complain that investors, especially VCs, demand too much control over company operations. This […] January 13, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2021 The 21 European Biotech Companies To Watch in 2021 As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies likely to make a big splash in the biotechnology sector over the next year. There were many memorable moments for the European biotech industry in 2020. The Covid-19 pandemic took over the media and many […] January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
In Depth 6 Jan 2021 The Bio-Based Economy: What’s Holding It Back? As pollution and climate change become growing problems, breaking society’s addiction to fossil fuels is a daunting task. What are the main obstacles holding European biotechs back from building a more sustainable economy and how can we resolve them? Modern society’s dependence on fossil fuels is unsustainable. Although the Covid-19 pandemic caused a 7% drop […] January 6, 2021 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 4 Jan 2021 What Does the Next Decade Have in Store for European Biotech? Just like that, another decade has gone by. It’s time to look at what the future will bring to the European biotech industry. European biotech has seen some huge breakthroughs and a few setbacks during the last 10 years. As we enter a new decade with great uncertainty due to the global Covid-19 pandemic, let’s […] January 4, 2021 - 9 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email